Determinants and functions of CAFs secretome during cancer progression and therapy
Open accessAbstract
Multiple lines of evidence are indicating that cancer development and malignant progression are not exclusively epithelial cancer cell-autonomous processes but may also depend on crosstalk with the surrounding tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) are abundantly represented in the TME and are continuously interacting with cancer cells. CAFs are regulating key mechanisms during progression to metastasis and response to treatment by enhancing cancer cells survival and aggressiveness. The latest advances in CAFs biology are pointing to CAFs-secreted factors as druggable targets and companion tools for cancer diagnosis and prognosis. Especially, extensive research conducted in the recent years has underscored the potential of several cytokines as actionable biomarkers that are currently evaluated in the clinical setting. In this review, we explore the current understanding of CAFs secretome determinants and functions to discuss their clinical implication in oncology.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The prevalent stromal contingent in CMS4 colorectal cancer is likely to contribute to resistance mechanisms.
“In terms of TME contexture, the prevalent stromal contingent is likely to contribute to resistance mechanisms, for instance through ECM deposition and cancer cells insulation (54), co-migration with cancer cells to metastatic sites (70), chemotherapy-induced secretome fostering metastasis, angiogenesis, immune evasion and/or drug resistance (71), or even drug retention, as demonstrated in the case”
From Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine (2024) · cites this paper as [71]
Stromal contribution to resistance in CMS4 colorectal cancer occurs through chemotherapy-induced secretome fostering metastasis, angiogenesis, immune evasion and/or drug resistance.
“chemotherapy-induced secretome fostering metastasis, angiogenesis, immune evasion and/or drug resistance (71)”
From Clinical Challenges of Consensus Molecular Subtype CMS4 Colon Cancer in the Era of Precision Medicine (2024) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
2 retracted
Dong, H., Hu, J., Zou, K., Ye, M., Chen, Y., Wu, C., Chen, X., & Han, M. (2019) · Molecular Cancer · doi:10.1186/s12943-018-0931-9 · Cited by 247 · see citing works
RetractedYu, B., Wu, K., Wang, X., Zhang, J., Wang, L., Jiang, Y., Zhu, X., Chen, W., & Yan, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1116-6 · Cited by 121 · see citing works
RetractedShedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369 · see citing works
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · see citing works
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400 · see citing works
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366 · see citing works
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 3× · see citing works
“It is widely accepted that the functional phenotype of CAFs is in part determined by the cell of origin, including but not restricted to local resident fibroblasts (D’Arcangelo et al., 2020; Sahai et al., 2020).”
BackgroundInfluentialOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759 · see citing works
VEGF in signaling and disease: beyond discovery and development
Apte, R. S., Chen, D. S., & Ferrara, N. (2019) · Cell · doi:10.1016/j.cell.2019.01.021 · Cited by 2,721 · see citing works
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681 · see citing works
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590 · see citing works
Transforming Growth Factor-β Signaling in Immunity and Cancer
Batlle, E., & Massagué, J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.024 · Cited by 2,366 · see citing works
Elyada, E., Bolisetty, M., Laise, P., Flynn, W. F., Courtois, E. T., Burkhart, R. A., Teinor, J. A., Belleau, P., Biffi, G., Lucito, M. S., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0094 · Cited by 2,241 · see citing works
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144 · cited 3× · see citing works
“Importantly, a vast body of evidence suggests that RT enhances paracrine signaling between fibroblasts and cancer cells through the IGF and TGF-beta pathways (Barker et al., 2015; Tommelein et al., 2018).”
BackgroundFeig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100 · see citing works
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085 · see citing works
TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851 · see citing works
Self-citationMicroenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847 · see citing works
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
Vermeulen, L., De Sousa E Melo, F., van der Heijden, M., Cameron, K., de Jong, J. H., Borovski, T., Tuynman, J. B., Todaro, M., Merz, C., Rodermond, H., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2048 · Cited by 1,804 · see citing works
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Straussman, R., Morikawa, T., Shee, K., Barzily-Rokni, M., Qian, Z. R., Du, J., Davis, A., Mongare, M. M., Gould, J., Frederick, D. T., et al. (2012) · Nature · doi:10.1038/nature11183 · Cited by 1,771 · see citing works
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Costa, A., Kieffer, Y., Scholer-Dahirel, A., Pelon, F., Bourachot, B., Cardon, M., Sirven, P., Magagna, I., Fuhrmann, L., Bernard, C., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.011 · Cited by 1,705 · cited 5× · see citing works
“CXCL-12 and enhancing immunosuppressive T regulatory cells (Treg) capacity to block T effector cells proliferation (Costa et al., 2018).”
BackgroundResultInfluentialStromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Ömeroğlu, G., Meterissian, S. H., Ömeroğlu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687 · see citing works
Phenotype molding of stromal cells in the lung tumor microenvironment
Lambrechts, D., Wauters, E., Boeckx, B., Aibar, S., Nittner, D., Burton, O., Bassez, A., Decaluwé, H., Pircher, A., Van den Eynde, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0096-5 · Cited by 1,648 · see citing works
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621 · see citing works
Erez, N., Truitt, M., Olson, P., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.041 · Cited by 1,515 · see citing works
Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R. P., Chaudhry, S. I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2756 · Cited by 1,478 · see citing works
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466 · see citing works
Biffi, G., Oni, T. E., Spielman, B., Hao, Y., Elyada, E., Park, Y., Preall, J., & Tuveson, D. A. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0710 · Cited by 1,360 · see citing works
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339 · see citing works
Cellular senescence promotes adverse effects of chemotherapy and cancer relapse
Demaria, M., O'Leary, M. N., Chang, J., Shao, L., Liu, S., Alimirah, F., Koenig, K., Le, C., Mitin, N., Deal, A. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0241 · Cited by 1,338 · see citing works
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell · doi:10.1016/j.cell.2018.01.009 · Cited by 1,230 · see citing works
Sherman, M. H., Yu, R. T., Engle, D. D., Ding, N., Atkins, A. R., Tiriac, H., Collisson, E. A., Connor, F., Van Dyke, T., Kozlov, S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.007 · Cited by 1,158 · see citing works
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · see citing works
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134 · see citing works
Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
Sousa, C. M., Biancur, D. E., Wang, X., Halbrook, C. J., Sherman, M. H., Zhang, L., Kremer, D., Hwang, R. F., Witkiewicz, A. K., Ying, H., et al. (2016) · Nature · doi:10.1038/nature19084 · Cited by 1,122 · see citing works
Qu, L., Ding, J., Chen, C. Y., Wu, Z., Liu, B., Gao, Y., Chen, W., Liu, F., Sun, W. C., Li, X., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.03.004 · Cited by 1,116 · see citing works
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
Calon, A., Lonardo, E., Berenguer-Llergo, A., Espinet, E., Hernando-Momblona, X., Iglesias, M., Sevillano, M., Palomo-Ponce, S., Tauriello, D. V. F., Byrom, D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3225 · Cited by 1,070 · see citing works
Self-citationAcerbi, I., Cassereau, L., Dean, I. S., Shi, Q., Au, A., Park, C., Chen, Y. Y., Liphardt, J., Hwang, E. S., & Weaver, V. M. (2015) · Integrative Biology · doi:10.1039/c5ib00040h · Cited by 1,062 · see citing works
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Calon, A., Espinet, E., Palomo-Ponce, S., Tauriello, D. V. F., Iglesias, M., Céspedes, M. V., Sevillano, M., Nadal, C., Jung, P., Zhang, X. H.-F., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.013 · Cited by 1,060 · see citing works
Self-citationBIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
Hilberg, F., Roth, G. J., Krssak, M., Kautschitsch, S., Sommergruber, W., Tontsch-Grunt, U., Garin-Chesa, P., Bader, G., Zoephel, A., Quant, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6307 · Cited by 1,056 · see citing works
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996 · see citing works
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995 · see citing works
Reck, M., Kaiser, R., Mellemgaard, A., Douillard, J.-Y., Orlov, S., Krzakowski, M., von Pawel, J., Gottfried, M., Bondarenko, I., Liao, M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70586-2 · Cited by 951 · see citing works
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918 · see citing works
Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben‐Porath, I., Önder, T. T., Wang, Z. C., Richardson, A. L., Weinberg, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013805107 · Cited by 851 · see citing works
Bartoschek, M., Oskolkov, N., Bocci, M., Lövrot, J., Larsson, C., Sommarin, M., Madsen, C. D., Lindgren, D., Pekar, G., Karlsson, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07582-3 · Cited by 826 · see citing works
Sun, Y., Campisi, J., Higano, C., Beer, T. M., Porter, P., Coleman, I., True, L., & Nelson, P. S. (2012) · Nature Medicine · doi:10.1038/nm.2890 · Cited by 793 · see citing works
Yeung, C. L. A., Co, N.-N., Tsuruga, T., Yeung, T.-L., Kwan, S., Leung, C. S., Li, Y., Lu, E. S., Kwan, K., Wong, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms11150 · Cited by 776 · see citing works
Hu, J. L., Wang, W., Lan, X. L., Zeng, Z. C., Liang, Y. S., Yan, Y. R., Song, F. Y., Wang, F. F., Zhu, X. H., Liao, W. J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1019-x · Cited by 773 · see citing works
Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2973 · Cited by 748 · see citing works
Sansone, P., Savini, C., Kurelac, I., Chang, Q., Amato, L. B., Strillacci, A., Степанова, А., Iommarini, L., Mastroleo, C., Daly, L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704862114 · Cited by 732 · see citing works
Bremnes, R. M., Dønnem, T., Al-Saad, S., Al-Shibli, K., Andersen, S., Sirera, R., Camps, C., Marinez, I., & Busund, L.-T. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f8a1bd · Cited by 691 · see citing works
Chakravarthy, A., Khan, L., Bensler, N. P., Bose, P., & De Carvalho, D. D. (2018) · Nature Communications · doi:10.1038/s41467-018-06654-8 · Cited by 656 · see citing works
Tan, W., Zhang, W., Strasner, A., Grivennikov, S. I., Cheng, J. Q., Hoffman, R. M., & Karin, M. (2011) · Nature · doi:10.1038/nature09707 · Cited by 647 · see citing works
Yano, S., Wang, W., Li, Q., Matsumoto, K., Sakurama, H., Nakamura, T., Ogino, H., Kakiuchi, S., Hanibuchi, M., Nishioka, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1643 · Cited by 643 · see citing works
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response
Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., Leblanc, M., Coulter, S., He, M., Scott, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.028 · Cited by 622 · see citing works
Crawford, Y., Kasman, I. M., Yu, L., Zhong, C., Wu, X., Modrusan, Z. D., Kaminker, J. S., & Ferrara, N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.004 · Cited by 613 · see citing works
Hirata, E., Girotti, M. R., Viros, A., Hooper, S., Spencer-Dene, B., Matsuda, M., Larkin, J., Marais, R., & Sahai, E. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.008 · Cited by 593 · see citing works
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., Donatis, A. D., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 586 · see citing works
Ene–Obong, A., Clear, A. J., Watt, J., Wang, J., Fatah, R., Riches, J. C., Marshall, J. F., Chin–Aleong, J., Chelala, C., Gribben, J. G., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.025 · Cited by 579 · see citing works
Van Cutsem, E., Tempero, M. A., Sigal, D., Oh, D.-Y., Fazio, N., Macarulla, T., Hitre, E., Hammel, P., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00590 · Cited by 499 · see citing works
Lan, Y., Zhang, D., Xu, C., Hance, K. W., Marelli, B., Qi, J., Yu, H., Qin, G., Sircar, A., Hernández, V. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5488 · Cited by 494 · see citing works
Newman, A. C., Nakatsu, M. N., Chou, W., Gershon, P. D., & Hughes, C. C. W. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-05-0393 · Cited by 492 · see citing works
Nissen, N. I., Karsdal, M. A., & Willumsen, N. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1110-6 · Cited by 492 · see citing works
Pietras, K., Pahler, J. C., Bergers, G., & Hanahan, D. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050019 · Cited by 452 · see citing works
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446 · see citing works
Chen, W.-J., Ho, C., Chang, Y., Chen, H., Ling, T., Ling, T., Yuan, S., Yuan, S.-S., Chen, Y.-J. L., Lin, C.-Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4472 · Cited by 442 · see citing works
Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis
Nielsen, S. R., Quaranta, V., Linford, A., Emeagi, P., Rainer, C., Santos, A., Ireland, L., Sakai, T., Sakai, K., Kim, Y.-S., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3340 · Cited by 441 · see citing works
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
Webber, J. P., Spary, L. K., Sanders, A. J., Chowdhury, R., Jiang, W. G., Steadman, R., Wymant, J. M., Jones, A. T., Kynaston, H., Mason, M. D., et al. (2014) · Oncogene · doi:10.1038/onc.2013.560 · Cited by 438 · see citing works
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
Salgado, R., Junius, S., Benoy, I. H., van Dam, P. A., Vermeulen, P., Marck, E. V., Huget, P., & Dirix, L. Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10833 · Cited by 435 · see citing works
Yang, L., Achreja, A., Yeung, T.-L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.011 · Cited by 433 · see citing works
Putoczki, T. L., Thiem, S., Loving, A., Busuttil, R. A., Wilson, N. J., Ziegler, P. K., Nguyen, P. M., Preaudet, A., Farid, R., Edwards, K. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.017 · Cited by 423 · see citing works
Froeling, F. E. M., Feig, C., Chelala, C., Dobson, R., Mein, C. A., Tuveson, D. A., Clevers, H. C., Hart, I. R., & Kocher, H. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.047 · Cited by 421 · see citing works
Matrix stiffening promotes a tumor vasculature phenotype
Bordeleau, F., Mason, B. N., Lollis, E. M., Mazzola, M. C., Zanotelli, M. R., Somasegar, S., Califano, J. P., Montague, C. R., LaValley, D. J., Huynh, J., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613855114 · Cited by 419 · see citing works
Tsuyada, A., Chow, A., Wu, J., Somlo, G., Chu, P. G., Loera, S., Luu, T. H., Li, A. X., Wu, X., Ye, W., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3567 · Cited by 408 · see citing works
Chun, E., Lavoie, S., Michaud, M., Gallini, C. A., Kim, J., Soucy, G., Odze, R., Glickman, J. N., & Garrett, W. S. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.024 · Cited by 402 · cited 1× · see citing works
“Similarly, FAP+ CAF-secreted CCL-2 mediates STAT-3 pathway activation in MDSC to promote liver tumor growth and to suppress T cells proliferation during colorectal carcinogenesis (Chun et al., 2015; Yang et al., 2016).”
BackgroundSignaling by members of the TGF-β family in vascular morphogenesis and disease
Pardali, E., Goumans, M., & ten Dijke, P. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.06.006 · Cited by 402 · see citing works
Pelon, F., Bourachot, B., Kieffer, Y., Magagna, I., Mermet‐Meillon, F., Bonnet, I., Costa, A., Givel, A.-M., Atieh, Y., Barbazán, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14134-w · Cited by 392 · see citing works
Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
Coward, J. I. G., Kulbe, H., Chakravarty, P., Leader, D., Vassileva, V., Leinster, D. A., Thompson, R. D., Schioppa, T., Nemeth, J., VERMEULEN, J. T., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0945 · Cited by 388 · see citing works
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Scherz-Shouval, R., Santagata, S., Mendillo, M. L., Sholl, L. M., Ben-Aharon, I., Beck, A. H., Dias-Santagata, D., Koeva, M., Stemmer, S. M., Whitesell, L., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.045 · Cited by 386 · see citing works
Qin, X., Guo, H.-Y., Wang, X.-N., Zhu, X.-Q., Yan, M., Wang, X., Xu, Q., Shi, J.-B., Lu, E., Chen, W., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1604-0 · Cited by 386 · see citing works
Sánchez-Elsner, T., Botella, L. M., Velasco, B., Corbí, A. L., Attisano, L., & Bernabéu, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104536200 · Cited by 379 · see citing works
Albrengues, J., Bertero, T., Grasset, E. M., Bonan, S., Maiel, M., Bourget, I., Philippe, C., Herráiz, C., Benamar, S., Croce, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms10204 · Cited by 369 · see citing works
Wu, X., Pan, T., Zhou, Q., Li, J., Yu, Z., Wang, X., Li, J., Li, C., Yan, M., Zhu, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15119 · Cited by 367 · see citing works
Holmgaard, R. B., Schaer, D. A., Li, Y., Castaneda, S. P., Murphy, M. Y., Xu, X., Inigo, I., Dobkin, J., Manro, J. R., Iversen, P. W., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0356-4 · Cited by 356 · see citing works
Zhang, R., Qi, F., Zhao, F., Li, G., Shao, S., Zhang, X., Yuan, L., & Feng, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1435-2 · Cited by 343 · see citing works
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Balsamo, M., Scordamaglia, F., Pietra, G., Manzini, C., Cantoni, C., Boitano, M., Queirolo, P., Vermi, W., Facchetti, F., Moretta, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906481106 · Cited by 327 · see citing works
Goulet, C. R., Champagne, A., Bernard, G., Vandal, D., Chabaud, S., Pouliot, F., & Bolduc, S. (2019) · BMC Cancer · doi:10.1186/s12885-019-5353-6 · Cited by 322 · see citing works
Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
Unterleuthner, D., Neuhold, P., Schwarz, K., Janker, L., Neuditschko, B., Nivarthi, H., Crnčec, I., Kramer, N., Unger, C., Hengstschläger, M., et al. (2019) · Angiogenesis · doi:10.1007/s10456-019-09688-8 · Cited by 301 · see citing works
Neuzillet, C., Tijeras‐Raballand, A., Ragulan, C., Cros, J. F., Patil, Y., Martinet, M., Erkan, M., Kleeff, J. H., Wilson, J. S., Apte, M. V., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5224 · Cited by 296 · see citing works
Metabolism shapes the tumor microenvironment
Reina‐Campos, M., Moscat, J., & Díaz-Meco, M. T. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.05.006 · Cited by 295 · see citing works
Extracellular vesicles in the tumor microenvironment: old stories, but new tales
Han, L., Lam, E. W. ‐., & Sun, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0980-8 · Cited by 295 · see citing works
Melisi, D., Garcia-Carbonero, R., Macarulla, T., Pezet, D., Deplanque, G., Fuchs, M., Trojan, J., Oettle, H., Kozloff, M., Cleverly, A., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0246-z · Cited by 294 · see citing works
Becker, L. M., O’Connell, J. T., Vo, A. P., Cain, M. P., Tampe, D., Bizarro, L., Sugimoto, H., McGow, A. K., Asara, J. M., Lovisa, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107701 · Cited by 293 · see citing works
Zhou, X., Yan, T., Huang, C., Xu, Z., Wang, L., Jiang, E., Wang, H., Yang, C., Liu, K., Shao, Z., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0911-3 · Cited by 285 · see citing works
Qiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S. B., Shipitsin, M. V., Trivett, M. K., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 282 · see citing works
Matsuo, Y., Ochi, N., Sawai, H., Yasuda, A., Takahashi, H., Funahashi, H., Takeyama, H., Tong, Z., & Guha, S. (2008) · International Journal of Cancer · doi:10.1002/ijc.24040 · Cited by 280 · see citing works
Prognostic relevance of cancer-associated fibroblasts in human cancer
Paulsson, J., & Micke, P. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.02.006 · Cited by 275 · see citing works
RNA Trafficking by Acute Myelogenous Leukemia Exosomes
Huan, J., Hornick, N. I., Shurtleff, M. J., Skinner, A. M., Goloviznina, N. A., Roberts, C. T., & Kurre, P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2184 · Cited by 259 · see citing works
Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer
Zhang, Z., Karthaus, W. R., Lee, Y. S., Gao, V. R., Wu, C., Russo, J. W., Liu, M., Mota, J. M., Abida, W. M., Linton, E. L., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.005 · Cited by 259 · see citing works
Zhuang, J., Lu, Q., Shen, B., Huang, X., Shen, L., Zheng, X., Huang, R., Yan, J., & Guo, H. (2015) · Scientific Reports · doi:10.1038/srep11924 · Cited by 252 · see citing works
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors
Ireland, L., Santos, A., Ahmed, M. S., Rainer, C., Nielsen, S. R., Quaranta, V., Weyer-Czernilofsky, U., Engle, D. D., Pérez-Mancera, P. A., Coupland, S. E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1201 · Cited by 241 · see citing works
Cancer metabolism, stemness and tumor recurrence
Curry, J., Tuluc, M., Whitaker‐Menezes, D., Ames, J. A., Anantharaman, A., Butera, A., Leiby, B. E., Cognetti, D. M., Sotgia, F., Lisanti, M. P., et al. (2013) · Cell Cycle · doi:10.4161/cc.24092 · Cited by 235 · see citing works
Fibroblast growth factors are required for efficient tumor angiogenesis.
Compagni, A., Wilgenbus, P., Impagnatiello, M.-A., Cotten, M. L., & Christofori, G. (2000) · PubMed · Cited by 227 · see citing works
Fang, Y., Zhou, W., Rong, Y., Kuang, T., Xu, X., Wu, W., Wang, D., & Lou, W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111543 · Cited by 223 · see citing works
Dorff, T., Goldman, B., Pinski, J., Mack, P., Lara, P., Veldhuizen, P. V., Quinn, D., Vogelzang, N., Thompson, I., & Hussain, M. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3122 · Cited by 219 · see citing works
Cho, H., Seo, Y., Loke, K. M., Kim, S.-W., Oh, S.-M., Kim, J.-H., Soh, J., Kim, H. S., Lee, H., Kim, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0125 · Cited by 212 · see citing works
Deng, F., Peng, L., Li, Z., Tan, G., Liang, E., Chen, S., Zhao, X., & Zhi, F. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0244-8 · Cited by 208 · see citing works
Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells
Yang, X., Li, Y., Zou, L., & Zhu, Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00356 · Cited by 205 · see citing works
Lu, S., Herrington, H. C., Reh, D. D., Weber, S. M., Bornstein, S., Wang, D., Li, A. G., Tang, C.-F., Siddiqui, Y., Nord, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1413306 · Cited by 204 · see citing works
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
Gibellini, L., Biasi, S. D., Paolini, A., Borella, R., Boraldi, F., Mattioli, M., Tartaro, D. L., Fidanza, L., Caro‐Maldonado, A., Meschiari, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013001 · Cited by 199 · see citing works
Ma, H., Wang, J., Zhao, X., Wu, T., Huang, Z., Chen, D., Liu, Y., & Ouyang, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2019.12.075 · Cited by 197 · see citing works
The Role of the Estrogen Pathway in the Tumor Microenvironment
Rothenberger, N. J., Somasundaram, A., & Stabile, L. P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020611 · Cited by 193 · see citing works
Deng, Y., Cheng, J., Fu, B., Liu, W., Chen, G., Zhang, Q., & Yang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.273 · Cited by 188 · see citing works
Ng, K., Nimeiri, H. S., McCleary, N. J., Abrams, T. A., Yurgelun, M. B. B., Cleary, J. M., Rubinson, D. A., Schrag, D., Miksad, R. A., Bullock, A. J., et al. (2019) · JAMA · doi:10.1001/jama.2019.2402 · Cited by 184 · see citing works
Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Hooijer, G. K. J., Meijer, S. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820459116 · Cited by 183 · see citing works
Altered TGF-β Signaling in a Subpopulation of Human Stromal Cells Promotes Prostatic Carcinogenesis
Franco, O. E., Jiang, M., Strand, D. W., Peacock, J. W., Fernandez, S., Jackson, R. S., Revelo, M. P., Bhowmick, N. A., & Hayward, S. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3142 · Cited by 181 · see citing works
Wei, L., Ye, H., Li, G., Lu, Y., Zhou, Q., Zheng, S., Lin, Q., Liu, Y., Li, Z., & Chen, R. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1104-x · Cited by 179 · see citing works
Bhagat, T. D., Ahrens, D. V., Dawlaty, M. M., Zou, Y., Baddour, J., Achreja, A., Zhao, H., Yang, L., Patel, B., Kwak, C., et al. (2019) · eLife · doi:10.7554/elife.50663 · Cited by 170 · see citing works
Tommelein, J., Vlieghere, E. D., Verset, L., Melsens, E., Leenders, J., Descamps, B., Debucquoy, A., Vanhove, C., Pauwels, P., Gespach, C. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0524 · Cited by 167 · see citing works
Pontiggia, O., Sampayo, R. G., Raffo, D., Motter, A. N., Xu, R., Bissell, M. J., Joffé, E. B. D. K., & Simian, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1766-x · Cited by 166 · see citing works
Sun, L., Xu, K., Cui, J. R., Yuan, D., Zou, B., Li, J., Liu, J., Li, K., Meng, Z. H., & Zhang, B. (2019) · Oncology Reports · doi:10.3892/or.2019.7255 · Cited by 166 · see citing works
Regulation of the mammalian heat shock factor 1
Naidu, S. D., & Dinkova‐Kostova, A. T. (2017) · FEBS Journal · doi:10.1111/febs.13999 · Cited by 159 · see citing works
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
Li, J., Eu, J. Q., Kong, L. R., Wang, L., Lim, Y. C., Goh, B. C., & Wong, A. L. (2020) · Molecules · doi:10.3390/molecules25204831 · Cited by 159 · see citing works
Immunocytokines: a novel class of potent armed antibodies
Pasche, N., & Neri, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.01.007 · Cited by 156 · see citing works
Rai, A., Greening, D. W., Chen, M., Xu, R., Ji, H. L., & Simpson, R. J. (2018) · PROTEOMICS · doi:10.1002/pmic.201800148 · Cited by 156 · see citing works
Vainer, N., Dehlendorff, C., & Johansen, J. S. (2018) · Oncotarget · doi:10.18632/oncotarget.25661 · Cited by 153 · see citing works
Isaacs, C. J., Robert, N. J., Bailey, F. A., Schuster, M. W., Overmoyer, B. A., Graham, M. L., Cai, B., Beach, K. J., Loewy, J. W., & Kaye, J. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.11.3368 · Cited by 149 · see citing works
Calvo, F., Ranftl, R., Hooper, S., Farrugia, A. J., Moeendarbary, E., Bruckbauer, A., Batista, F., Charras, G., & Sahai, E. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.11.052 · Cited by 142 · see citing works
Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression
Tang, D., Gao, J., Wang, S., Ye, N., Chong, Y., Huang, Y., Wang, J., Li, B., Yin, W., & Wang, D. (2016) · Tumor Biology · doi:10.1007/s13277-015-3942-9 · Cited by 138 · see citing works
Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
Neri, D. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0622 · Cited by 136 · see citing works
Cancer-associated fibroblasts in radiotherapy: challenges and new opportunities
Wang, Z., Tang, Y., Tan, Y., Wei, Q., & Yu, W. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0362-2 · Cited by 136 · see citing works
Carapuça, E., Gemenetzidis, E., Feig, C., Bapiro, T. E., Williams, M. D., Wilson, A. S., Delvecchio, F. R., Arumugam, P., Grose, R. P., Lemoine, N. R., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4727 · Cited by 135 · see citing works
Li, W.-Q., Zhang, X., Wang, J., Li, M., Cao, C., Tan, J.-H., Ma, D., & Gao, Q.-L. (2017) · OncoTarget · doi:10.18632/oncotarget.21635 · Cited by 134 · see citing works
Fan, J., Xu, G., Chang, Z., Zhu, L., & Yao, J. (2020) · Clinical Science · doi:10.1042/cs20200039 · Cited by 134 · see citing works
Scharl, M. M., Frei, S. M., Pesch, T., Kellermeier, S., Arikkat, J. M., Frei, P., Fried, M., Weber, A., Jehle, E. C., Rühl, A., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300498 · Cited by 133 · see citing works
The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis
Noma, K., Smalley, K. S. M., Lioni, M., Naomoto, Y., Tanaka, N., El‐Deiry, W. S., King, A. J., Nakagawa, H., & Herlyn, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.061 · Cited by 132 · see citing works
Gao, M., Kim, B. G., Kang, S., Choi, Y. P., Park, H., Kang, K. S., & Cho, N. H. (2010) · Journal of Cell Science · doi:10.1242/jcs.072900 · Cited by 132 · see citing works
Tao, L., Huang, G., Wang, R., Pan, Y., He, Z., Chu, X., Song, H., & Chen, L. (2016) · Scientific Reports · doi:10.1038/srep38408 · Cited by 131 · see citing works
Yamaguchi, H., & Sakai, R. (2015) · Cancers · doi:10.3390/cancers7040876 · Cited by 130 · see citing works
Ziani, L., Safta, T. B., Gourbeix, J., Cavalcanti, A., Robert, C., Favre, G., Chouaı̈b, S., & Thiery, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15540 · Cited by 128 · see citing works
Yang, J., Yang, L., Lin, Y., Zheng, Z., Fang, J., He, S., & Zhuang, S. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.09.012 · Cited by 127 · see citing works
Tempero, M. A., Cutsem, E. V., Sigal, D. S., Oh, D., Fazio, N., Macarulla, T. M., Hitre, E., Hammel, P. R., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.2020.38.4_suppl.638 · Cited by 125 · see citing works
The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma
Ha, S. Y., Yeo, S.-Y., Xuan, Y.-H., & Kim, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099955 · Cited by 124 · see citing works
Tumour-stroma ratio and prognosis in gastric adenocarcinoma
Kemi, N., Eskuri, M., Herva, A., Leppänen, J., Huhta, H. I., Helminen, O., Saarnio, J., Karttunen, T. J., & Kauppila, J. H. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0202-y · Cited by 121 · see citing works
ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells
Safina, A. F., Vandette, E., & Bakin, A. V. (2006) · Oncogene · doi:10.1038/sj.onc.1210046 · Cited by 120 · see citing works
Xiao, Q., Zhou, D., Rucki, A. A., Williams, J., Zhou, J., Mo, G., Murphy, A. G., Fujiwara, K., Kleponis, J., Salman, B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3264 · Cited by 119 · see citing works
Cancer-associated fibroblasts support vascular growth through mechanical force
Sewell-Loftin, M. K., Bayer, S. V. H., Crist, E., Hughes, T., Joison, S. M., Longmore, G. D., & George, S. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-13006-x · Cited by 118 · see citing works
Wei, L., Ye, H., Li, G., Lu, Y., Zhou, Q., Zheng, S., Lin, Q., Liu, Y., Li, Z., & Chen, R. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03420-5 · Cited by 118 · see citing works
Zhou, Z., Zhou, Q., Wu, X., Xu, S., Hu, X., Tao, X., Li, B., Peng, J., Li, D., Shen, L., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.039 · Cited by 118 · see citing works
Qin, X., Yan, M., Zhang, J., Wang, X., Shen, Z., Lv, Z., Li, Z., Wei, W., & Chen, W. (2016) · Scientific Reports · doi:10.1038/srep20587 · Cited by 117 · see citing works
Zhao, F., Evans, K., Xiao, C., DeVito, N., Theivanthiran, B., Holtzhausen, A., Siska, P. J., Blobe, G. C., & Hanks, B. A. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0086 · Cited by 117 · cited 1× · see citing works
“Interestingly, the authors reported increased TGFBR-2 expression upon treatment (Zhao et al., 2018).”
BackgroundBordignon, P., Bottoni, G., Xu, X., Popescu, A. S., Truan, Z., Guenova, E., Kofler, L., Jafari, P., Ostano, P., Röcken, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.092 · Cited by 117 · see citing works
Morishita, R. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.712 · Cited by 114 · see citing works
Berdiel‐Acer, M., Pamplona, R. S., Calon, A., Cuadras, D., Berenguer, A., Sanjuán, X., Paúles, M. J., Salazar, R., Moreno, V. R., Batlle, E., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.04.006 · Cited by 112 · see citing works
Self-citationNaito, Y., Yamamoto, Y., Sakamoto, N., Shimomura, I., Kogure, A., Kumazaki, M., Yokoi, A., Yashiro, M., Kiyono, T., Yanagihara, K., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0832-4 · Cited by 112 · see citing works
D’Arcangelo, E., Wu, N. C., Cadavid, J. L., & McGuigan, A. P. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0705-1 · Cited by 112 · see citing works
A core matrisome gene signature predicts cancer outcome
Yuzhalin, A. E., Urbonas, T., Silva, M. A., Muschel, R. J., & Gordon-Weeks, A. N. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.458 · Cited by 110 · see citing works
Vaquero, J., Lobe, C., Tahraoui, S., Clapéron, A., Mergey, M., Merabtene, F., Wendum, D., Coulouarn, C., Housset, C., Desbois‐Mouthon, C., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3725 · Cited by 108 · see citing works
Ryner, L. C., Guan, Y., Firestein, R., Xiao, Y., Choi, Y., Rabe, C., Lu, S., Fuentes, E., Huw, L., Lackner, M. R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3111 · Cited by 107 · see citing works
BRAF Inhibition Generates a Host–Tumor Niche that Mediates Therapeutic Escape
Smalley, I., Wargo, J. A., Flaherty, K. T., Messina, J. L., & Smalley, K. S. M. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.329 · Cited by 105 · see citing works
Wang, Z., Xiong, S., Mao, Y., Chen, M., Ma, X., Zhou, X., Ma, Z., Liu, F., Huang, Z., Luo, Q., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4747 · Cited by 105 · see citing works
Cioni, B., Nevedomskaya, E., Melis, M. H. M., van Burgsteden, J. A., Stelloo, S., Hodel, E., Spinozzi, D., de Jong, J., van der Poel, H. G., de Boer, J. P., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12327 · Cited by 105 · see citing works
Dai, G., Yao, X., Zhang, Y., Gu, J., Geng, Y.-F., Xue, F., & Zhang, J. (2018) · Bulletin du Cancer · doi:10.1016/j.bulcan.2017.12.009 · Cited by 103 · see citing works
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses
Westrich, J. A., Vermeer, D. W., Colbert, P. L., Spanos, W. C., & Pyeon, D. (2020) · Molecular Carcinogenesis · doi:10.1002/mc.23188 · Cited by 103 · see citing works
Ansems, M., & Span, P. N. (2020) · Clinical and Translational Radiation Oncology · doi:10.1016/j.ctro.2020.04.001 · Cited by 100 · see citing works
Enduring epigenetic landmarks define the cancer microenvironmentPreprint
Pidsley, R., Lawrence, M. G., Zotenko, E., Niranjan, B., Statham, A. L., Song, J. Z., Chabanon, R. M., Qu, W., Wang, H., Richards, M. G., et al. (2018) · Genome Research · doi:10.1101/gr.229070.117 · Cited by 98 · see citing works
Rupp, T., Langlois, B., Koczorowska, M. M., Radwańska, A., Sun, Z., Hussenet, T., Lefèbvre, O., Murdamoothoo, D., Arnold, C., Klein, A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.012 · Cited by 97 · see citing works
Giussani, M., Triulzi, T., Sozzi, G., & Tagliabue, E. (2019) · Cells · doi:10.3390/cells8020081 · Cited by 97 · see citing works
Principe, S., Mejia‐Guerrero, S., Ignatchenko, V., Sinha, A., Ignatchenko, A., Shi, W., Pereira, K., Su, S., Huang, S. H., O’Sullivan, B., et al. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00925 · Cited by 96 · see citing works
POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer
Karlan, B. Y., Dering, J., Walsh, C., Oršulić, S., Lester, J., Anderson, L. A., Ginther, C., Fejzo, M. S., & Slamon, D. J. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.021 · Cited by 95 · see citing works
Song, L.-X., Smith, M., Doshi, P., Sasser, K., Fulp, W., Altiok, S., & Haura, E. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000193 · Cited by 94 · see citing works
THBS2 is a Potential Prognostic Biomarker in Colorectal Cancer
Wang, X. B., Zhang, L., Li, H., Sun, W., Zhang, H., & Lai, M. (2016) · Scientific Reports · doi:10.1038/srep33366 · Cited by 94 · see citing works
Wang, J., Wu, X., Xiao-juan, G., & Jiang, X. (2018) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504018x15336368805108 · Cited by 94 · see citing works
Dourado, M. R., Korvala, J., Åström, P., de Oliveira, C. E., Cervigne, N. K., Mofatto, L. S., Bastos, D. C., Messetti, A. C., Graner, E., Leme, A. F. P., et al. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1578525 · Cited by 93 · see citing works
Rødningen, O. K., Overgaard, J., Alsner, J., Hastie, T. J., & Børresen‐Dale, A. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.09.020 · Cited by 92 · see citing works
Olapade-Olaopa, E. O., MacKay, E. H., Taub, N. A., SANDHU, D. P. S., Terry, T. R., & Habib, F. K. (1999) · PubMed · Cited by 92 · see citing works
Epigenetic Control of the Tumor Microenvironment
Marks, D. L., Olson, R. L., & Fernández-Zapico, M. E. (2016) · Epigenomics · doi:10.2217/epi-2016-0110 · Cited by 91 · see citing works
Arwert, E. N., Milford, E. L., Rullan, A., Derzsi, S., Hooper, S., Kato, T., Mansfield, D., Melcher, A., Harrington, K. J., & Sahai, E. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0527-7 · Cited by 90 · see citing works
Liu, Z., Kobayashi, K., van Dinther, M., van Heiningen, S. H., Valdimarsdóttir, G., van Laar, T., Scharpfenecker, M., Löwik, C. W. G. M., Goumans, M., ten Dijke, P., et al. (2009) · Journal of Cell Science · doi:10.1242/jcs.048942 · Cited by 89 · see citing works
Dourado, M. R., Guerra, E. N. S., Salo, T. A., Lambert, D., & Coletta, R. D. (2017) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12623 · Cited by 88 · see citing works
Stromal Androgen Receptor in Prostate Development and Cancer
Singh, M., Jha, R., Melamed, J., Shapiro, E., Hayward, S. W., & Lee, P. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.06.022 · Cited by 87 · see citing works
Jiang, K., Liu, H., Xie, D., & Xiao, Q. (2019) · Oncology Letters · doi:10.3892/ol.2019.9952 · Cited by 87 · see citing works
Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms
Unger, C., Kramer, N., Unterleuthner, D., Scherzer, M., Burian, A., Rudisch, A., Stadler, M., Schlederer, M., Lenhardt, D., Riedl, A., et al. (2017) · Oncogene · doi:10.1038/onc.2017.116 · Cited by 85 · see citing works
Yu, S., Xia, S., Yang, D., Wang, K., Yeh, S., Gao, Z., & Chang, C. (2013) · Medical Oncology · doi:10.1007/s12032-013-0674-9 · Cited by 81 · see citing works
Sjöberg, E., Augsten, M., Bergh, J. C. S., Jirström, K., & Östman, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.104 · Cited by 80 · see citing works
ATRA modulates mechanical activation of TGF-β by pancreatic stellate cells
Sarper, M., Cortés, E., Lieberthal, T. J., & Hernández, A. E. D. R. (2016) · Scientific Reports · doi:10.1038/srep27639 · Cited by 80 · see citing works
Li, D., Qu, C., Ning, Z., Wang, H., Zang, K., Zhuang, L., Chen, L., Wang, P., & Meng, Z. (2016) · PubMed Central · Cited by 80 · see citing works
Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior
Giusti, I., Francesco, M. D., D'Ascenzo, S., Palmerini, M., Macchiarelli, G., Carta, G., & Dolo, V. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1451286 · Cited by 80 · see citing works
Li, Y., Li, C. X., Ye, H., Chen, F., Melamed, J., Peng, Y., Liu, J., Wang, Z., Tsou, H. C., Wei, J., et al. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00279.x · Cited by 79 · see citing works
MiRNAs Derived from Cancer-Associated Fibroblasts in Colorectal Cancer
Savardashtaki, A., Shabaninejad, Z., Movahedpour, A., Sahebnasagh, R., Mirzaei, H., & Hamblin, M. R. (2019) · Epigenomics · doi:10.2217/epi-2019-0110 · Cited by 79 · see citing works
Epigenetics in modulating immune functions of stromal and immune cells in the tumor microenvironment
Pan, X., & Zheng, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0505-9 · Cited by 75 · see citing works
Toste, P. A., Nguyen, A. H., Kadera, B. E., Duong, M., Wu, N., Elliott, I. A., Tran, L. M., Bikhchandani, M., Li, L., Patel, S. G., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0348 · Cited by 74 · see citing works
Gorchs, L., Hellevik, T., Bruun, J., Camilio, K. A., Al‐Saad, S., Stuge, T. B., & Martínez-Zubiaurre, I. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00087 · Cited by 71 · see citing works
Dörsam, B., Bösl, T., Reiners, K. S., Barnert, S., Schubert, R., Shatnyeva, O., Zigrino, P., Engert, A., Hansen, H. P., & von Strandmann, E. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01358 · Cited by 69 · see citing works
CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia
Lewinsky, H., Barak, A. F., Huber, V., Kramer, M. P., Radomir, L., Sever, L., Orr, I., Mirkin, V., Dezorella, N., Shapiro, M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96610 · Cited by 69 · see citing works
CXCR2 signaling promotes secretory cancer‐associated fibroblasts in pancreatic ductal adenocarcinoma
Awaji, M. I., Saxena, S., Wu, L., Prajapati, D. R., Purohit, A., Varney, M. L., Sushil Kumar, K., Rachagani, S., Ly, Q. P., Jain, M., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902990r · Cited by 69 · see citing works
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation
Clocchiatti, A., Ghosh, S., Procopio, M.-G., Mazzeo, L., Bordignon, P., Ostano, P., Goruppi, S., Bottoni, G., Katarkar, A., Levesque, M. P., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99159 · Cited by 68 · see citing works
Umakoshi, M., Takahashi, S., Itoh, G., Kuriyama, S., Sasaki, Y., Yanagihara, K., Yashiro, M., Maeda, D., Goto, A., & Tanaka, M. (2018) · Oncogene · doi:10.1038/s41388-018-0564-x · Cited by 68 · see citing works
Prognostic Significance in Breast Cancer of a Gene Signature Capturing Stromal PDGF Signaling
Frings, O., Augsten, M., Tobin, N. P., Carlson, J. W., Paulsson, J., Peña, C., Olsson, E., Veerla, S., Bergh, J. C. S., Östman, A., et al. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.02.018 · Cited by 67 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Asif, P. J., Longobardi, C., Hahne, M., & Medema, J. P. (2021) · Cancers · doi:10.3390/cancers13184720 · Cited by 245 · see citing works
Liu, Y., Sinjab, A. F., Min, J., Han, G., Paradiso, F., Zhang, Y., Wang, R., Pei, G., Dai, Y., Liu, Y., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.03.004 · Cited by 249 · see citing works
CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion
Günaydın, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.668349 · Cited by 205 · see citing works
Rihawi, K., Ricci, A. D., Rizzo, A., Brocchi, S., Marasco, G., Pastore, L. V., Llimpe, F. L. R., Golfieri, R., & Renzulli, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083805 · Cited by 165 · see citing works
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Sarkar, M., Nguyen, T., Gundre, E., Ogunlusi, O., El-Sobky, M. H., Giri, B., & Sarkar, T. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089068 · Cited by 135 · see citing works
Cancer-Associated Fibroblasts: Mechanisms of Tumor Progression and Novel Therapeutic Targets
Czekay, R., Cheon, D., Samarakoon, R., Kutz, S. M., & Higgins, P. J. (2022) · Cancers · doi:10.3390/cancers14051231 · Cited by 115 · see citing works
TME-Related Biomimetic Strategies Against Cancer
Peng, C., Xu, Y., Wu, J., Wu, D., Zhou, L., & Xia, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s441135 · Cited by 90 · see citing works
Manoukian, P., Bijlsma, M. F., & van Laarhoven, H. W. M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743907 · Cited by 89 · see citing works
Metin, C. U., & Özcan, G. (2022) · BMC Cancer · doi:10.1186/s12885-022-09736-5 · Cited by 85 · see citing works
Ziani, L., Buart, S., Chouaı̈b, S., & Thiery, J. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1950953 · Cited by 80 · see citing works
Differentiation of the tumor microenvironment: are CAFs the Organizer?
Kochetkova, M., & Samuel, M. S. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2021.11.008 · Cited by 76 · see citing works
Targeting of the tumor immune microenvironment by metformin
Wu, Z., Zhang, C., & Najafi, M. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00648-w · Cited by 75 · see citing works
A comprehensive review of pancreatic cancer and its therapeutic challenges
Jiang, S., Fagman, J. B., Ma, Y., Liu, J., Vihav, C., Engström, C., Liu, B., & Chen, C. (2022) · Aging · doi:10.18632/aging.204310 · Cited by 74 · see citing works
Jia, M., Zhang, D., Zhang, C., & Li, C. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01134-6 · Cited by 70 · see citing works
Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
Lan, X., Li, W., Zhao, K., Wang, J., Li, S., & Hai, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582532 · Cited by 72 · see citing works
Rivas, E. I., Linares, J., Zwick, M., Gómez‐Llonín, A., Guiu, M., Labernadie, A., Badia-Ramentol, J., Lladó, A., Bardia, L., Pérez-Núñez, I., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32782-3 · Cited by 67 · see citing works
Self-citationLee, Y. E., Go, G.-Y., Koh, E.-Y., Yoon, H.-N., Seo, M., Hong, S.-M., Jeong, J. H., Kim, J.-C., Cho, D., Kim, T. S., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006130 · Cited by 61 · see citing works
Tissue mechanics in tumor heterogeneity and aggression
Finger, A., Hendley, A. M., Figueroa, D. A., Velozo, H. G., & Weaver, V. M. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.004 · Cited by 59 · see citing works
Chuangchot, N., Jamjuntra, P., Yangngam, S., Luangwattananun, P., Thongchot, S., Junking, M., Thuwajit, P., Yenchitsomanus, P., & Thuwajit, C. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01684-7 · Cited by 57 · see citing works
Cancer-Associated Fibroblasts: Implications for Cancer Therapy
Maia, A. R. R., & Wiemann, S. (2021) · Cancers · doi:10.3390/cancers13143526 · Cited by 53 · see citing works
Pakravan, K., Mohammadi, M. M., Ghazimoradi, M. H., Cho, W. C. S., Sadeghizadeh, M., & Babashah, S. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03780-2 · Cited by 49 · see citing works
Pradhan, R., Paul, S., Das, B., Sinha, S., Dash, S. R., Mandal, M., & Kundu, C. N. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109257 · Cited by 51 · see citing works
Imodoye, S. O., Adedokun, K. A., & Bello, I. O. (2024) · Histochemistry and Cell Biology · doi:10.1007/s00418-023-02258-6 · Cited by 47 · see citing works
Mouillet-Richard, S., Cazelles, A., Sroussi, M., Gallois, C., Taieb, J., & Laurent-Puig, P. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3964 · Cited by 43 · see citing works
Chen, H., Yang, W., Xue, X., Li, Y., Jin, Z., & Ji, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415970 · Cited by 40 · see citing works
Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives
Toledo, B., Picon‐Ruiz, M., Marchal, J. A., & Perán, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415576 · Cited by 39 · see citing works
Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer
Mishra, D., & Banerjee, D. (2023) · Cells · doi:10.3390/cells12040628 · Cited by 36 · see citing works
Minini, M., & Fouassier, L. (2023) · Current Oncology · doi:10.3390/curroncol30040319 · Cited by 36 · see citing works
The role of cancer-associated fibroblasts in the invasion and metastasis of colorectal cancer
Yin, J., Zhu, W., Feng, S., Yan, P., & Qin, S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1375543 · Cited by 35 · see citing works
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., Cho, W. C. S., & Mansoori, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121361 · Cited by 34 · see citing works
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing
Perucca, A., Gómez‐Llonín, A., Benach, O. M., Hallopeau, C., Rivas, E. I., Linares, J., Garrido, M., Sallent-Aragay, A., Golde, T., Colombelli, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56275-1 · Cited by 31 · see citing works
Self-citationInterplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity
Mentucci, F. M., Ferrara, M. G., Ercole, A., Vittar, N. B. R., & Lamberti, M. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1515390 · Cited by 29 · see citing works
Chen, Z., Zhuo, S., He, G., Tang, J., Hao, W., Gao, W., Yang, K., & Xu, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.721897 · Cited by 28 · see citing works
Iozzo, M., Sgrignani, G., Comito, G., Chiarugi, P., & Giannoni, E. (2021) · Cells · doi:10.3390/cells10123396 · Cited by 28 · see citing works
The Convergence of FTIR and EVs: Emergence Strategy for Non-Invasive Cancer Markers Discovery
Wong, L.-W., Mak, S.-H., Goh, B. H., & Lee, W.-L. (2022) · Diagnostics · doi:10.3390/diagnostics13010022 · Cited by 25 · see citing works
Ahuja, S., Sureka, N., & Zaheer, S. (2024) · Apmis · doi:10.1111/apm.13447 · Cited by 25 · see citing works
Spunde, K., Korotkaja, K., & Zajakina, A. (2022) · Biomedicines · doi:10.3390/biomedicines10092142 · Cited by 25 · see citing works
CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
Coursier, D., & Calvo, F. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00931-z · Cited by 23 · see citing works
Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Vitorakis, N., Gargalionis, A. N., Papavassiliou, K. A., Adamopoulos, C., & Papavassiliou, A. G. (2024) · Cancers · doi:10.3390/cancers16162876 · Cited by 22 · see citing works
Nano-Drug Delivery Systems Targeting CAFs: A Promising Treatment for Pancreatic Cancer
Wang, M., Xue, W., Yuan, H., Wang, Z., & Yu, L. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s451151 · Cited by 23 · see citing works
Mahboobnia, K., Beveridge, D. J., Yeoh, G. C., Kabir, T. D., & Leedman, P. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179393 · Cited by 23 · see citing works
Schwager, S. C., Young, K. M., Hapach, L. A., Carlson, C. M., Mosier, J. A., McArdle, T. J., Wang, W., Schunk, C. T., Jayathilake, A. L., Bates, M. E., et al. (2022) · eLife · doi:10.7554/elife.74433 · Cited by 20 · see citing works
Koppensteiner, L., Mathieson, L., Neilson, L., O’Connor, R. A., & Akram, A. R. (2025) · FEBS Letters · doi:10.1002/1873-3468.15083 · Cited by 16 · see citing works
Linares, J., Varese, M., Sallent-Aragay, A., Méndez-Vicente, A., Palomo‐Ponce, S., Iglesias, M., Batlle, E., Pisonero, J., Montagut, C. O., Giralt, E., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01717 · Cited by 16 · see citing works
Self-citationSamart, P., Palliyage, G. H., Issaragrisil, S., Luanpitpong, S., & Rojanasakul, Y. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01158-5 · Cited by 16 · see citing works
Milián, L., Monleón-Guinot, I., Sancho‐Tello, M., Galbis, J. M., Cremades, A., Almenar-Ordaz, M., Peñaroja-Martinez, J., Farrás, R., de Llano, J. J. M., Cardá, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126766 · Cited by 16 · see citing works
Chen, X., Jia, M., Ji, J., Zhao, Z., & Zhao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.887532 · Cited by 15 · see citing works
Feng, Y., Jiang, Y., Yang, L., Lu, D., Li, N., Zhang, Q., Yang, H., Qin, H., Zhang, J., Gou, X., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108586 · Cited by 14 · see citing works
FGFR4 promotes CAF activation through the CXCL10-CXCR3 axis in colon cancer
Sun, E. G., Choi, J., Park, M., Kim, D., Sung, M., Shim, H.-J., Hwang, J., Bae, W., Jung, C., Kim, Y., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07588-y · Cited by 14 · see citing works
3D printing to construct in vitro multicellular models of melanoma
Sang, S., Wang, X., Duan, J., Cao, Y., Shen, Z., Sun, L., Duan, Q., & Liu, Z. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28429 · Cited by 13 · see citing works
The tumor microenvironment: adding pieces to the puzzle
Aguilar‐Cázares, D., Perez-Medina, M., Benito-Lopez, J. J., Galicia-Velasco, M., Meneses-Flores, M., Camarena, Á., & López-González, J. S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1731338 · Cited by 13 · see citing works
Cheon, I., Lee, S., Oh, S., & Ahn, Y. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102194 · Cited by 12 · see citing works
Dhungel, N., & Dragoi, A. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1379971 · Cited by 12 · see citing works
Natesh, N. R., Mogha, P., Chen, A., Antonia, S. J., & Varghese, S. (2024) · APL Bioengineering · doi:10.1063/5.0188238 · Cited by 11 · see citing works
Mansour, A. M. A., Khattab, M. M., El-Khatib, A. S., Awaad, A. K., El-Refaie, W. M., & El-Mezayen, N. S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122939 · Cited by 10 · see citing works
Akanda, M. R., Lubaba, U., Rahman, M. K., Islam, A., Akter, M., Islam, M. S., Uddin, M. N., & Park, B. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155918 · Cited by 10 · see citing works
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
Cerro, P. A., Mascaraque, M., Gallego-Rentero, M., Almenara‐Blasco, M., Morala, J. N., Santiago, J. L., González, S., Gracia‐Cazaña, T., Juarranz, Á., & Gilaberte, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.970279 · Cited by 10 · see citing works
Dhungel, N., Youngblood, R., Chu, M., Carroll, J. L., & Dragoi, A. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1096326 · Cited by 10 · see citing works
Matarrese, P., Vona, R., Ascione, B., Cittadini, C., Tocci, A., & Mileo, A. M. (2023) · Cells · doi:10.3390/cells12071048 · Cited by 10 · see citing works
Agostino, S. D., Padula, D. L., Rago, V., Gabriele, C., Conforti, F., Aprigliano, E., Urlandini, L., Parrotta, E. I., Lofaro, D., Vescio, F., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03496-3 · Cited by 10 · see citing works
Cancer-associated fibroblasts in osteosarcoma: key players in immune escape and targeted therapy
Fan, J., Jin, Y., Lv, F., Wu, W., Sun, L., & Wang, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1668535 · Cited by 8 · see citing works
Molavand, M., Majidinia, M., & Yousefi, B. (2025) · IUBMB Life · doi:10.1002/iub.70074 · Cited by 8 · see citing works
Jiang, Y., Ning, Y., Cheng, S., Huang, Y., Deng, M., & Chen, C. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01922-5 · Cited by 8 · see citing works
TiME for a change: The tumor microenvironment as the missing piece in cancer therapeutics
Mo, J., Zhang, H., & Swarbrick, A. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003276 · Cited by 7 · see citing works
Proto, M., Fiore, D., Bifulco, M., & Gazzerro, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713427 · Cited by 7 · see citing works
Mostafavi, S., & Hassan, Z. M. (2023) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2023.043926 · Cited by 7 · see citing works
Liu, X., Li, H., Wang, Y., Zhang, Q., Liu, Y., & Liu, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-91036-6 · Cited by 6 · see citing works
TRIM16 mediates secretory autophagy in head and neck cancer-associated fibroblasts
Ly, T., Pickard, B., Pandey, A., Yap, M., Opara, J. K., Arnold, L., Martínez-Rivera, N., Rosa‐Molinar, E., New, J., Werner, L. R., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2508064 · Cited by 6 · see citing works
Pessa, J. C., Paavolainen, O., Hästbacka, H. S. E., Puustinen, M. C., Silva, A. J. D., Pihlström, S., Gramolelli, S., Boström, P., Hartiala, P., Peuhu, E., et al. (2025) · Science Advances · doi:10.1126/sciadv.ady1289 · Cited by 6 · see citing works
Kim, J. Y., Moon, S., & Kim, D. (2022) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2022.23.12.4315 · Cited by 6 · see citing works
Wu, N. C., Quevedo, R., Nurse, M., Hezaveh, K., Liu, H., Sun, F., Muffat, J., Sun, Y., Simmons, C. A., McGaha, T. L., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122879 · Cited by 5 · see citing works
Packirisamy, S., André, O., Fan, Z., Nordenfelt, P., & Swaminathan, V. (2026) · Advanced Science · doi:10.1002/advs.202517631 · Cited by 5 · see citing works
Chang, J., Lo, Z. H. Y., Alenizi, S., & Kovačević, Ž. (2023) · Cancers · doi:10.3390/cancers15102779 · Cited by 4 · see citing works
Phankeaw, P., Khanaruksombat, S., Numprasit, W., Jamjuntra, P., Augsornworawat, P., Warnnissorn, M., Thuwajit, P., & Thuwajit, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-28439-y · Cited by 4 · see citing works
Suba, Z. (2024) · Current Oncology · doi:10.3390/curroncol31090362 · Cited by 4 · see citing works
Pessa, J. C., Paavolainen, O., Puustinen, M. C., Hästbacka, H. S. E., Silva, A. J. D., Pihlström, S., Gramolelli, S., Boström, P., Hartiala, P., Peuhu, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.24.600354 · Cited by 4 · see citing works
Iglesias, M., Badia-Ramentol, J., Martínez‐Ciarpaglini, C., Linares, J., Tarazona, N., Mulet-Margalef, N., Tornero-Piñero, P., Sallent-Aragay, A., Recort-Bascuas, A., Gibert, J., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-336804 · Cited by 3 · see citing works
Self-citationYang, J.-P., Kulkarni, N. N., Yamaji, M., Shiraishi, T., Pham, T. Q., Do, H., Aiello, N. M., Shaw, M. H., Nakamura, T., Abiru, A., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0314227 · Cited by 3 · see citing works
Luca, G. D., Petrillo, G., Scognamiglio, I., Pane, K., Cocca, L., Roscigno, G., Mascolo, M., Pignataro, C., Verde, S., Fraticelli, A., et al. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05781-y · Cited by 3 · see citing works
Tumor Microenvironment: Multiway Role in Drug Resistance
Hurrah, I. M., Mintoo, M. J., Fatima, K., Kousar, R., Mohiuddin, T., Wani, A., & Khan, S. U. (2024) · Springer eBooks · doi:10.1007/978-981-97-1666-1_5 · Cited by 3 · see citing works
Biophysical Regulation of TGFβ Signaling in the Tumor Microenvironment
Sankhe, C. S., Sacco, J. L., & Gomez, E. W. (2023) · Current cancer research · doi:10.1007/978-3-031-22802-5_6 · Cited by 3 · see citing works
Zhao, L., Han, Y., Du, J., & Zhao, X. (2026) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2026.113170 · Cited by 2 · see citing works
Fibroblasts Promote Resistance to KRAS Silencing in Colorectal Cancer Cells
Mendonça, S., Carvalho, P. D., Serra‐Roma, A., Oliveira, P., Ribeiro, A., Carvalho, J., Martins, F., Machado, A. L., Oliveira, M. J., & Velho, S. (2024) · Cancers · doi:10.3390/cancers16142595 · Cited by 2 · see citing works
Steitz, A. M., Reinartz, S., Beutgen, V. M., Müller, R., von Strandmann, E. P., & Gómez‐Serrano, M. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104823 · Cited by 2 · see citing works
The Role of Inflammatory Cells in Tumor Angiogenesis
Tamma, R., Annese, T., & Ribatti, D. (2022) · Biology of extracellular matrix · doi:10.1007/978-3-030-99708-3_14 · Cited by 2 · see citing works
Itoh, G., Fukushi, Y., Takagane, K., Kanetaka, K., Suzuki, H., Kawasaki, Y., Kuriyama, S., Iemura, K., Tanaka, K., Goto, A., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03317-6 · Cited by 1 · see citing works
Carter, A. T., Fabiano, A. R., Aalaei, E., Deng, J. Z., Rostant, D. E., & King, M. R. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202600011 · Cited by 1 · see citing works
Szwedowicz, U., Dębicka, R., Pawlik, K. J., Przystupski, D., & Choromańska, A. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119283 · Cited by 1 · see citing works
Chen, X., Hou, H., Xiang, Z., Zhou, Y., Xiao, L., Peng, L., Tang, X., Wang, J. J., Song, M., Jin, X., et al. (2026) · Fundamental Research · doi:10.1016/j.fmre.2026.05.011 · Cited by 1 · see citing works
Blackledge, C. W., Gullion, S., McCabe, I. C., Van, N. N. K., Hariharan, A., Luan, C., Peng, X. L., Polacheck, W. J., Yeh, J. J., & Shelton, S. E. (2026) · Angiogenesis · doi:10.1007/s10456-026-10061-9 · Cited by 1 · see citing works
Алексеенко, И. В., Zhukova, L., Kondratyeva, L. G., Buzdin, A. A., Чернов, И. П., & Sverdlov, E. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910454 · Cited by 1 · see citing works
Boosting antitumor immunity in breast cancers: Potential of adjuvants, drugs, and nanocarriers
Chen, P., Ren, L., Guo, Y., & Sun, Y. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2432499 · Cited by 1 · see citing works
Wu, N. C., Quevedo, R., Nurse, M., Hezaveh, K., Liu, H., Sun, F., Muffat, J., Sun, Y., Simmons, C. A., McGaha, T. L., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.17.549300 · Cited by 1 · see citing works
Palliyage, G. H. (2023) · doi:10.33915/etd.12138 · Cited by 1 · see citing works
Mendonça, S., Carvalho, P. D., Serra‐Roma, A., Oliveira, P., Ribeiro, A., Carvalho, J., Martins, F., Machado, A. L., Oliveira, M. J., & Velho, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.19.590324
Srinivas, P., Latha, N. R., Jaikumar, V. S., Varghese, G. R., Krithiga, K., Krishnan, N., Warrier, A. V., & Patra, D. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5055933
Boyacıoğlu, Ö., Kalali, B. D., Reçber, T., Gelen-Gungor, D., Nemutlu, E., Eroğlu, İ., Kılıç, N., & Korkusuz, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-29726-4
Samart, P., Heenatigala Palliyage, G., Issaragrisil, S., Luanpitpong, S., & Rojanasakul, Y. (2024) · Figshare · doi:10.6084/m9.figshare.24532259
- Authors
- Linares, J., Marín-Jiménez, J. A., Badia-Ramentol, J., & Calon, A.
- Affiliations
- Hospital Del Mar (ES)
- Corresponding author
- Calon, Alexandre
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2021-01-22
- Volume
- 8
- Pages
- 621070-621070
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC7862334
- OpenAlex
- W3121447922
- Cited by
- 110
- References
- 244
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 26 · 2023: 21 · 2022: 18 · 2021: 11
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, cc-by)
- Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, other-oa)
- Funders
- Instituto de Salud Carlos III (CP16/00151, PI17/00211)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Keywords
- cancer-associated fibroblasts, tumor microenvironment, tumor progression, metastasis, cancer therapy response, cytokines, biomarkers, druggable targets, cancer diagnosis and prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review